Condition: Cancer-associated Thrombosis · Venous Thromboembolism · Gynecologic Cancer · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
This description comes directly from the study's public registry record.
Roberto Pola, PhD; MD · +39 0630157075 · roberto.pola@policlinicogemelli.it
Paolo Santini, MD · paolo.santini@guest.policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Agostino Gemelli University Polyclinic Foundation IRCCS | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06284343